雪榕生物跌2.08%，成交额2.36亿元，主力资金净流出1333.73万元

Group 1 - The core viewpoint of the news is that Xue Rong Biological has experienced a decline in stock price despite a significant increase in its stock value year-to-date, indicating potential volatility in the market [1][2] - As of October 14, Xue Rong Biological's stock price was 6.58 CNY per share, with a market capitalization of 4.126 billion CNY and a trading volume of 236 million CNY [1] - The company has seen a year-to-date stock price increase of 89.63%, with a 9.30% increase over the last five trading days [1] Group 2 - Xue Rong Biological operates in the agricultural sector, specifically in the cultivation and sale of edible mushrooms, with a revenue composition of 73.31% from enoki mushrooms and 22.27% from king oyster mushrooms [1][2] - As of June 30, the number of shareholders decreased by 14.57% to 30,200, while the average circulating shares per person increased by 28.64% to 17,119 shares [2] - For the first half of 2025, the company reported a revenue of 791 million CNY, a year-on-year decrease of 26.17%, and a net profit loss of 103 million CNY, which represents a year-on-year increase of 28.58% [2] Group 3 - Since its A-share listing, Xue Rong Biological has distributed a total of 236 million CNY in dividends, with no dividends paid in the last three years [3]